{
  "drug_name": "zink",
  "nbk_id": "NBK611984",
  "url": "https://www.ncbi.nlm.nih.gov/books/NBK611984/",
  "scraped_at": "2026-01-11T15:41:56",
  "sections": {
    "clinical_significance": "Awareness of the increased incidence of malignancy in a patient population is the first step in improving patient care through targeted prevention and early detection strategies to reduce mortality and morbidity. This approach is crucial as it allows healthcare providers to recognize the elevated risk and prioritize timely interventions. By being aware, healthcare providers can implement targeted prevention strategies, including lifestyle modifications, the consideration of specific medications, and improved early detection through regular screenings and monitoring. These proactive measures can lead to earlier diagnoses, which are often associated with better treatment outcomes, thereby reducing mortality and morbidity. Ultimately, this awareness forms the foundation for a more informed, strategic approach to patient care, improving survival rates and quality of life for the affected population.\n\nPatients on immunosuppressive medications require heightened cancer screening, physician vigilance, and patient education due to their increased risk of developing malignancies. Immunosuppressive drugs weaken the body's immune surveillance, which is essential for identifying and eliminating cancer cells. This reduced immune function necessitates regular and thorough cancer screening for early detection and prompt treatment, ultimately improving patient outcomes and helping to mitigate the elevated cancer risk associated with long-term immunosuppressive therapy.\n\nFor patients more vulnerable to all forms of skin cancer, proactive steps should be taken to minimize modifiable risk factors. These measures include reducing UV exposure by using broad-spectrum sunscreens, wearing wide-brimmed hats and long-sleeve clothing, and scheduling regular full-body skin examinations.\n[42]\n[43]\nFor patients at higher risk of developing lymphoma, patient education should focus on the expected symptoms, such as painless lymphadenopathy, fever, night sweats, weight loss, and fatigue, along with regular follow-ups."
  }
}